Particle.news

AI Model Sybil Validated for Lung Cancer Risk Prediction in Diverse Populations

Presented at the ATS 2025 International Conference, Sybil demonstrates high accuracy in forecasting lung cancer risk using a single low-dose CT scan, paving the way for prospective clinical trials.

Overview

  • Sybil, a deep learning model developed by MIT and Harvard researchers, predicts lung cancer risk from a single low-dose CT scan without relying on demographic factors.
  • Validation results from over 21,000 individuals in South Korea show Sybil achieved 86% accuracy at one year and 74% at six years overall, with similar performance in never-smokers.
  • The model addresses rising lung cancer rates in nonsmokers, particularly in Asia, where current screening guidelines do not include low-risk groups.
  • Researchers aim to conduct prospective clinical trials to confirm Sybil’s clinical utility and expand its capabilities to predict outcomes like lung cancer-specific mortality.
  • Sybil’s ability to identify both low-risk individuals and those requiring closer monitoring could transform personalized lung cancer screening strategies globally.